The Competition and Markets Authority (CMA) has cleared the merger between the London Stock Exchange Group (LSEG) and Quantile following an in-depth investigation.
The CMA temporarily blocked the merger, worth around £274m, in May over concerns that the deal could be harmful to market competition.
Founded in 2015, Quantile is a fintech firm that aims to reduce regulatory costs and capital requirements for financial institutions that trade in derivative instruments through a process called multilateral compression.
Related: London Stock Exchange Considers Sale of Italian Unit To Secure Refinitiv Deal
The CMA’s concerns were that LSEG similarly provides cost-reduction services for financial institutions and investigated whether a merger would create an uncompetitive market.
The phase one investigation found there was some legitimacy to these concerns, prompting an in-depth phase two investigation. This saw the CMA engage with customers of the companies and third-party providers of similar services, ultimately deeming the market would not be hurt by the deal.
“The in-depth investigation and consultation allowed us to engage extensively with LSEG, Quantile, and their customers and competitors, enabling us to better understand the impact of the transaction on those businesses and the market,” said Martin Coleman, chair of the CMA independent inquiry group.
“On the basis of that engagement, and other evidence we have gathered, we are satisfied that this deal will not worsen the options available to businesses and consumers. As such, the transaction can go ahead.”
Featured News
College Sports Leaders in Intensive Talks to Settle NIL Antitrust Case Against NCAA
Apr 30, 2024 by
CPI
EU Investigates Facebook’s and Instagram’s Handling of Disinformation Ahead of Elections
Apr 30, 2024 by
CPI
Antitrust Lawsuit Targets Hotel Giants for Alleged Price Fixing with AI
Apr 30, 2024 by
CPI
ABA Seeks to Join FTC Lawsuit Against Amazon Over Antitrust Concerns
Apr 30, 2024 by
CPI
Google Agrees to Pay News Corp for AI-Related Content
Apr 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI